Carly Michele Prutzman, APRN, NP-C | |
1503 S Mission St Ste A, Anadarko, OK 73005-5815 | |
(405) 247-1100 | |
(405) 247-1155 |
Full Name | Carly Michele Prutzman |
---|---|
Gender | Female |
Speciality | Nurse Practitioner |
Experience | 8 Years |
Location | 1503 S Mission St Ste A, Anadarko, Oklahoma |
Accepts Medicare Assignments | May be. She may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1790235877 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
363LF0000X | Nurse Practitioner - Family | 86017 (Oklahoma) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Healthcare Stat Of Anadarko Inc | 5799074407 | 2 |
News Archive
An expert specializing in communications to the general public on the scientific techniques for assessing and interpreting the significance of human exposure to natural and synthetic chemicals is available to provide comment and analysis on the upcoming report on biomonitoring by the Centers for Disease Control and Prevention (CDC).
New Medicare reimbursement rules provide some relief to safety-net hospitals, shifting the burden of financial penalties toward hospitals serving wealthier patient populations, according to a new study led by Washington University School of Medicine in St. Louis.
AlphaRx Inc. announced today that it has signed an agreement that provides long-term supply of the active pharmaceutical ingredient (API) for ARX1088, an orally active interferon inducer intended for the adjunctive treatment of Hepatitis in China and other emerging markets. Under the agreement, Venturepharm will be the primary supplier of AlphaRx's worldwide requirements for the compound.
Teleflex Incorporated today announced that it has received 510(k) market clearance from the U.S. Food and Drug Administration (FDA) for the company's ArrowEVOLUTION™ PICC with Chlorag+ard™ technology, a peripherally inserted central catheter with a Chlorhexedine-based solution that has been chemically-bonded into the surface of the catheter both intra- and extralumenally. Teleflex will launch the product for general availability in the United States in the fourth quarter.
› Verified 6 days ago
Entity Name | Norman Regional Hospital Authority |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1912563727 PECOS PAC ID: 2769395185 Enrollment ID: O20031111000299 |
News Archive
An expert specializing in communications to the general public on the scientific techniques for assessing and interpreting the significance of human exposure to natural and synthetic chemicals is available to provide comment and analysis on the upcoming report on biomonitoring by the Centers for Disease Control and Prevention (CDC).
New Medicare reimbursement rules provide some relief to safety-net hospitals, shifting the burden of financial penalties toward hospitals serving wealthier patient populations, according to a new study led by Washington University School of Medicine in St. Louis.
AlphaRx Inc. announced today that it has signed an agreement that provides long-term supply of the active pharmaceutical ingredient (API) for ARX1088, an orally active interferon inducer intended for the adjunctive treatment of Hepatitis in China and other emerging markets. Under the agreement, Venturepharm will be the primary supplier of AlphaRx's worldwide requirements for the compound.
Teleflex Incorporated today announced that it has received 510(k) market clearance from the U.S. Food and Drug Administration (FDA) for the company's ArrowEVOLUTION™ PICC with Chlorag+ard™ technology, a peripherally inserted central catheter with a Chlorhexedine-based solution that has been chemically-bonded into the surface of the catheter both intra- and extralumenally. Teleflex will launch the product for general availability in the United States in the fourth quarter.
› Verified 6 days ago
Entity Name | Atoka County Healthcare Authority |
---|---|
Entity Type | Part A Provider - Critical Access Hospital |
Entity Identifiers | NPI Number: 1508896499 PECOS PAC ID: 9032003132 Enrollment ID: O20080514000253 |
News Archive
An expert specializing in communications to the general public on the scientific techniques for assessing and interpreting the significance of human exposure to natural and synthetic chemicals is available to provide comment and analysis on the upcoming report on biomonitoring by the Centers for Disease Control and Prevention (CDC).
New Medicare reimbursement rules provide some relief to safety-net hospitals, shifting the burden of financial penalties toward hospitals serving wealthier patient populations, according to a new study led by Washington University School of Medicine in St. Louis.
AlphaRx Inc. announced today that it has signed an agreement that provides long-term supply of the active pharmaceutical ingredient (API) for ARX1088, an orally active interferon inducer intended for the adjunctive treatment of Hepatitis in China and other emerging markets. Under the agreement, Venturepharm will be the primary supplier of AlphaRx's worldwide requirements for the compound.
Teleflex Incorporated today announced that it has received 510(k) market clearance from the U.S. Food and Drug Administration (FDA) for the company's ArrowEVOLUTION™ PICC with Chlorag+ard™ technology, a peripherally inserted central catheter with a Chlorhexedine-based solution that has been chemically-bonded into the surface of the catheter both intra- and extralumenally. Teleflex will launch the product for general availability in the United States in the fourth quarter.
› Verified 6 days ago
Entity Name | Healthcare Stat |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1609029644 PECOS PAC ID: 7012067762 Enrollment ID: O20090618000208 |
News Archive
An expert specializing in communications to the general public on the scientific techniques for assessing and interpreting the significance of human exposure to natural and synthetic chemicals is available to provide comment and analysis on the upcoming report on biomonitoring by the Centers for Disease Control and Prevention (CDC).
New Medicare reimbursement rules provide some relief to safety-net hospitals, shifting the burden of financial penalties toward hospitals serving wealthier patient populations, according to a new study led by Washington University School of Medicine in St. Louis.
AlphaRx Inc. announced today that it has signed an agreement that provides long-term supply of the active pharmaceutical ingredient (API) for ARX1088, an orally active interferon inducer intended for the adjunctive treatment of Hepatitis in China and other emerging markets. Under the agreement, Venturepharm will be the primary supplier of AlphaRx's worldwide requirements for the compound.
Teleflex Incorporated today announced that it has received 510(k) market clearance from the U.S. Food and Drug Administration (FDA) for the company's ArrowEVOLUTION™ PICC with Chlorag+ard™ technology, a peripherally inserted central catheter with a Chlorhexedine-based solution that has been chemically-bonded into the surface of the catheter both intra- and extralumenally. Teleflex will launch the product for general availability in the United States in the fourth quarter.
› Verified 6 days ago
Entity Name | Anibal Avila Md Professional Corporation Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1578855409 PECOS PAC ID: 0143407205 Enrollment ID: O20110527000226 |
News Archive
An expert specializing in communications to the general public on the scientific techniques for assessing and interpreting the significance of human exposure to natural and synthetic chemicals is available to provide comment and analysis on the upcoming report on biomonitoring by the Centers for Disease Control and Prevention (CDC).
New Medicare reimbursement rules provide some relief to safety-net hospitals, shifting the burden of financial penalties toward hospitals serving wealthier patient populations, according to a new study led by Washington University School of Medicine in St. Louis.
AlphaRx Inc. announced today that it has signed an agreement that provides long-term supply of the active pharmaceutical ingredient (API) for ARX1088, an orally active interferon inducer intended for the adjunctive treatment of Hepatitis in China and other emerging markets. Under the agreement, Venturepharm will be the primary supplier of AlphaRx's worldwide requirements for the compound.
Teleflex Incorporated today announced that it has received 510(k) market clearance from the U.S. Food and Drug Administration (FDA) for the company's ArrowEVOLUTION™ PICC with Chlorag+ard™ technology, a peripherally inserted central catheter with a Chlorhexedine-based solution that has been chemically-bonded into the surface of the catheter both intra- and extralumenally. Teleflex will launch the product for general availability in the United States in the fourth quarter.
› Verified 6 days ago
Entity Name | Healthcare Stat Of Anadarko Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1811359607 PECOS PAC ID: 5799074407 Enrollment ID: O20160519001701 |
News Archive
An expert specializing in communications to the general public on the scientific techniques for assessing and interpreting the significance of human exposure to natural and synthetic chemicals is available to provide comment and analysis on the upcoming report on biomonitoring by the Centers for Disease Control and Prevention (CDC).
New Medicare reimbursement rules provide some relief to safety-net hospitals, shifting the burden of financial penalties toward hospitals serving wealthier patient populations, according to a new study led by Washington University School of Medicine in St. Louis.
AlphaRx Inc. announced today that it has signed an agreement that provides long-term supply of the active pharmaceutical ingredient (API) for ARX1088, an orally active interferon inducer intended for the adjunctive treatment of Hepatitis in China and other emerging markets. Under the agreement, Venturepharm will be the primary supplier of AlphaRx's worldwide requirements for the compound.
Teleflex Incorporated today announced that it has received 510(k) market clearance from the U.S. Food and Drug Administration (FDA) for the company's ArrowEVOLUTION™ PICC with Chlorag+ard™ technology, a peripherally inserted central catheter with a Chlorhexedine-based solution that has been chemically-bonded into the surface of the catheter both intra- and extralumenally. Teleflex will launch the product for general availability in the United States in the fourth quarter.
› Verified 6 days ago
Entity Name | Healthcare Stat Of Newcastle Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1346796604 PECOS PAC ID: 2769760768 Enrollment ID: O20161026001208 |
News Archive
An expert specializing in communications to the general public on the scientific techniques for assessing and interpreting the significance of human exposure to natural and synthetic chemicals is available to provide comment and analysis on the upcoming report on biomonitoring by the Centers for Disease Control and Prevention (CDC).
New Medicare reimbursement rules provide some relief to safety-net hospitals, shifting the burden of financial penalties toward hospitals serving wealthier patient populations, according to a new study led by Washington University School of Medicine in St. Louis.
AlphaRx Inc. announced today that it has signed an agreement that provides long-term supply of the active pharmaceutical ingredient (API) for ARX1088, an orally active interferon inducer intended for the adjunctive treatment of Hepatitis in China and other emerging markets. Under the agreement, Venturepharm will be the primary supplier of AlphaRx's worldwide requirements for the compound.
Teleflex Incorporated today announced that it has received 510(k) market clearance from the U.S. Food and Drug Administration (FDA) for the company's ArrowEVOLUTION™ PICC with Chlorag+ard™ technology, a peripherally inserted central catheter with a Chlorhexedine-based solution that has been chemically-bonded into the surface of the catheter both intra- and extralumenally. Teleflex will launch the product for general availability in the United States in the fourth quarter.
› Verified 6 days ago
Mailing Address | Practice Location Address |
---|---|
Carly Michele Prutzman, APRN, NP-C 3333 Windmill Rd, Oklahoma City, OK 73165-7382 Ph: () - | Carly Michele Prutzman, APRN, NP-C 1503 S Mission St Ste A, Anadarko, OK 73005-5815 Ph: (405) 247-1100 |
News Archive
An expert specializing in communications to the general public on the scientific techniques for assessing and interpreting the significance of human exposure to natural and synthetic chemicals is available to provide comment and analysis on the upcoming report on biomonitoring by the Centers for Disease Control and Prevention (CDC).
New Medicare reimbursement rules provide some relief to safety-net hospitals, shifting the burden of financial penalties toward hospitals serving wealthier patient populations, according to a new study led by Washington University School of Medicine in St. Louis.
AlphaRx Inc. announced today that it has signed an agreement that provides long-term supply of the active pharmaceutical ingredient (API) for ARX1088, an orally active interferon inducer intended for the adjunctive treatment of Hepatitis in China and other emerging markets. Under the agreement, Venturepharm will be the primary supplier of AlphaRx's worldwide requirements for the compound.
Teleflex Incorporated today announced that it has received 510(k) market clearance from the U.S. Food and Drug Administration (FDA) for the company's ArrowEVOLUTION™ PICC with Chlorag+ard™ technology, a peripherally inserted central catheter with a Chlorhexedine-based solution that has been chemically-bonded into the surface of the catheter both intra- and extralumenally. Teleflex will launch the product for general availability in the United States in the fourth quarter.
› Verified 6 days ago
Miss Andrea Hayes, APRN-CNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 412 Se 11th Street, Anadarko, OK 73005 Phone: 405-247-9500 Fax: 405-247-9505 | |
Kelly Nesdahl, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1503 S Mission St Ste A, Anadarko, OK 73005 Phone: 405-247-1100 | |
Frank Molina, ADVANCED NURSE PRACT Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 115 N.e. Oldtown Drive, Anadarko, OK 73005 Phone: 405-247-2458 Fax: 405-247-6657 | |
Wendy Marie Brown, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1002 E Central Blvd, Anadarko, OK 73005 Phone: 405-247-2551 | |
Randee Green, APRN-CNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1503 S Mission St, Anadarko, OK 73005 Phone: 405-247-1100 | |
Amy Lynne Glasgow, NP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 201 E Parker Mckenzie Dr, Anadarko, OK 73005 Phone: 405-247-7900 | |
Mrs. Tonya Kay Jones, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1503 S Mission St # A, Anadarko, OK 73005 Phone: 405-247-1100 Fax: 405-247-1155 |